These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 19696190)

  • 1. New-onset atrial fibrillation as first clinical manifestation of latent Brugada syndrome: prevalence and clinical significance.
    Pappone C; Radinovic A; Manguso F; Vicedomini G; Sala S; Sacco FM; Ciconte G; Saviano M; Ferrari M; Sommariva E; Sacchi S; Ciaccio C; Kallergis EM; Santinelli V
    Eur Heart J; 2009 Dec; 30(24):2985-92. PubMed ID: 19696190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of type 1 Brugada ECG pattern after administration of Class 1C drugs in patients with type 1 myotonic dystrophy: Myotonic dystrophy as a part of the Brugada syndrome.
    Maury P; Audoubert M; Cintas P; Rollin A; Duparc A; Mondoly P; Chiriac AM; Acket B; Zhao X; Pasquié JL; Cardin C; Delay M; Sadron M; Carrié D; Galinier M; Davy JM; Arne-Bès MC; Raczka F
    Heart Rhythm; 2014 Oct; 11(10):1721-7. PubMed ID: 25016148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation in a large population with Brugada electrocardiographic pattern: prevalence, management, and correlation with prognosis.
    Giustetto C; Cerrato N; Gribaudo E; Scrocco C; Castagno D; Richiardi E; Giachino D; Bianchi F; Barbonaglia L; Ferraro A
    Heart Rhythm; 2014 Feb; 11(2):259-65. PubMed ID: 24513919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial electrophysiological and structural remodeling in high-risk patients with Brugada syndrome: assessment with electrophysiology and echocardiography.
    Toh N; Morita H; Nagase S; Taniguchi M; Miura D; Nishii N; Nakamura K; Ohe T; Kusano KF; Ito H
    Heart Rhythm; 2010; 7(2):218-24. PubMed ID: 20129298
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brugada Syndrome Phenotype Elimination by Epicardial Substrate Ablation.
    Brugada J; Pappone C; Berruezo A; Vicedomini G; Manguso F; Ciconte G; Giannelli L; Santinelli V
    Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1373-81. PubMed ID: 26291334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SCN1Bb R214Q found in 3 patients: 1 with Brugada syndrome and 2 with lone atrial fibrillation.
    Olesen MS; Holst AG; Svendsen JH; Haunsø S; Tfelt-Hansen J
    Heart Rhythm; 2012 May; 9(5):770-3. PubMed ID: 22155598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated oxidative stress is associated with ventricular fibrillation episodes in patients with Brugada-type electrocardiogram without SCN5A mutation.
    Tanaka M; Nakamura K; Kusano KF; Morita H; Ohta-Ogo K; Miura D; Miura A; Nakagawa K; Tada T; Murakami M; Nishii N; Nagase S; Hata Y; Kohno K; Ouchida M; Shimizu K; Yutani C; Ohe T; Ito H
    Cardiovasc Pathol; 2011; 20(1):e37-42. PubMed ID: 20219395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydroquinidine therapy in Brugada syndrome.
    Hermida JS; Denjoy I; Clerc J; Extramiana F; Jarry G; Milliez P; Guicheney P; Di Fusco S; Rey JL; Cauchemez B; Leenhardt A
    J Am Coll Cardiol; 2004 May; 43(10):1853-60. PubMed ID: 15145111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence, clinical characteristics and management of atrial fibrillation in patients with Brugada syndrome.
    Rodríguez-Mañero M; Namdar M; Sarkozy A; Casado-Arroyo R; Ricciardi D; de Asmundis C; Chierchia GB; Wauters K; Rao JY; Bayrak F; Van Malderen S; Brugada P
    Am J Cardiol; 2013 Feb; 111(3):362-7. PubMed ID: 23206922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ventricular fibrillation in lone atrial fibrillation as clinical manifestation of latent Brugada syndrome: Usefulness of flecainide testing.
    Pappone C; Vicedomini G; Petretta A; Giannelli L; Cuko A; Santinelli V
    HeartRhythm Case Rep; 2015 Sep; 1(5):285-289. PubMed ID: 28491569
    [No Abstract]   [Full Text] [Related]  

  • 11. Simultaneous ST-segment elevation in the right precordial and inferior leads in Brugada syndrome.
    Lombardi F; Potenza S; Beltrami A; Verzoni A; Brugada P; Brugada R
    J Cardiovasc Med (Hagerstown); 2007 Mar; 8(3):201-4. PubMed ID: 17312439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brugada syndrome.
    Napolitano C; Priori SG
    Orphanet J Rare Dis; 2006 Sep; 1():35. PubMed ID: 16972995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A mutation in the sodium channel is responsible for the association of long QT syndrome and familial atrial fibrillation.
    Benito B; Brugada R; Perich RM; Lizotte E; Cinca J; Mont L; Berruezo A; Tolosana JM; Freixa X; Brugada P; Brugada J
    Heart Rhythm; 2008 Oct; 5(10):1434-40. PubMed ID: 18929331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Flecainide test in Brugada syndrome: a reproducible but risky tool.
    Gasparini M; Priori SG; Mantica M; Napolitano C; Galimberti P; Ceriotti C; Simonini S
    Pacing Clin Electrophysiol; 2003 Jan; 26(1P2):338-41. PubMed ID: 12687841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Doubts of the cardiologist regarding an electrocardiogram presenting QRS V1-V2 complexes with positive terminal wave and ST segment elevation. Consensus Conference promoted by the Italian Cardiology Society].
    Oreto G; Corrado D; Delise P; Fedele F; Gaita F; Gentile F; Giustetto C; Michelucci A; Padeletti L; Priori S
    G Ital Cardiol (Rome); 2010 Nov; 11(11 Suppl 2):3S-22S. PubMed ID: 21361048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of flecainide testing in unmasking SCN5A-related Brugada syndrome.
    Meregalli PG; Ruijter JM; Hofman N; Bezzina CR; Wilde AA; Tan HL
    J Cardiovasc Electrophysiol; 2006 Aug; 17(8):857-64. PubMed ID: 16764707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term follow-up of asymptomatic Brugada patients with inducible ventricular fibrillation under hydroquinidine.
    Bouzeman A; Traulle S; Messali A; Extramiana F; Denjoy I; Narayanan K; Marijon E; Hermida JS; Leenhardt A
    Europace; 2014 Apr; 16(4):572-7. PubMed ID: 24068450
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of cardiac sodium channel mutations on initiation of ventricular arrhythmias in patients with Brugada syndrome.
    Morita H; Nagase S; Miura D; Miura A; Hiramatsu S; Tada T; Murakami M; Nishii N; Nakamura K; Morita ST; Oka T; Kusano KF; Ohe T
    Heart Rhythm; 2009 Apr; 6(4):487-92. PubMed ID: 19324308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal transmural repolarization process in patients with Brugada syndrome.
    Sangawa M; Morita H; Nakatsu T; Nishii N; Miura D; Miura A; Tada T; Murakami M; Hiramatsu S; Nagase S; Nakamura K; Oka T; Toyonaga S; Mashima K; Kusachi S; Yamamoto K; Ohe T; Kusano KF
    Heart Rhythm; 2009 Aug; 6(8):1163-9. PubMed ID: 19632628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tpeak-Tend interval and Tpeak-Tend/QT ratio as markers of ventricular tachycardia inducibility in subjects with Brugada ECG phenotype.
    Letsas KP; Weber R; Astheimer K; Kalusche D; Arentz T
    Europace; 2010 Feb; 12(2):271-4. PubMed ID: 19897501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.